Variant position: 1546 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1590 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human EESESEAKSVKVKIKLNKKD DKGRDKGKGKKRPNRGKAKPV
Mouse EESESEAKSVKVKIKLNKKE EKGRDTGKGKKRPNRGKAKPV
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 1590 Probable global transcription activator SNF2L2
1506 – 1590 Disordered
1530 – 1552 Basic and acidic residues
1528 – 1528 Phosphoserine
Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia.
Koga M.; Ishiguro H.; Yazaki S.; Horiuchi Y.; Arai M.; Niizato K.; Iritani S.; Itokawa M.; Inada T.; Iwata N.; Ozaki N.; Ujike H.; Kunugi H.; Sasaki T.; Takahashi M.; Watanabe Y.; Someya T.; Kakita A.; Takahashi H.; Nawa H.; Muchardt C.; Yaniv M.; Arinami T.;
Hum. Mol. Genet. 18:2483-2494(2009)
Cited for: PROBABLE INVOLVEMENT IN SCZD; VARIANT GLU-1546; CHARACTERIZATION OF VARIANT GLU-1546;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.